Literature DB >> 12931132

Ethical, social and legal issues in pharmacogenomics.

D C Wertz1.   

Abstract

Keywords:  Genetics and Reproduction

Mesh：

Year:  2003        PMID： 12931132     DOI： 10.1038/sj.tpj.6500188

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  7 in total

1.  Racializing drug design: implications of pharmacogenomics for health disparities.

Authors:  Sandra Soo-Jin Lee
Journal:  Am J Public Health       Date:  2005-10-27       Impact factor: 9.308

Review 2.  Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.

Authors:  Susanne B Haga; Rachel Mills; Hayden Bosworth
Journal:  Patient Educ Couns       Date:  2014-06-21

Review 3.  A review of consent practices and perspectives for pharmacogenetic testing.

Authors:  Susanne B Haga; Rachel Mills
Journal:  Pharmacogenomics       Date:  2016-08-17       Impact factor: 2.533

Review 4.  Pharmacogenomics in early-phase clinical development.

Authors:  Tal Burt; Savita Dhillon
Journal:  Pharmacogenomics       Date:  2013-07       Impact factor: 2.533

Review 5.  Ethical and public policy challenges for pharmacogenomics.

Authors:  Elliot S Gershon; Ney Alliey-Rodriguez; Kay Grennan
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

6.  Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country.

Authors:  Nayyereh Ayati; Monireh Afzali; Mandana Hasanzad; Abbas Kebriaeezadeh; Ali Rajabzadeh; Shekoufeh Nikfar
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

7.  Ethics of genomic research.

Authors:  Jayanthi Mathaiyan; Adithan Chandrasekaran; Sanish Davis
Journal:  Perspect Clin Res       Date:  2013-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.